|
1
|
UNAIDS: 2012 UNAIDS Report on the Global
AIDS Epidemic. http://www.unaids.org/en/resources/publications/2012/name,76121,en.asp2012
Accessed. April 5–2017.
|
|
2
|
Crum-Cianflone N, Hullsiek KH, Marconi V,
Weintrob A, Ganesan A, Barthel RV, Fraser S, Agan BK and Wegner S:
Trends in the incidence of cancers among HIV-infected persons and
the impact of antiretroviral therapy: A 20-year cohort study. AIDS.
23:41–50. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schneider E, Whitmore S, Glynn KM,
Dominguez K, Mitsch A and McKenna MT: Centers for Disease Control
and Prevention (CDC): Revised surveillance case definitions for HIV
infection among adults, adolescents and children aged <18 months
and for HIV infection and AIDS among children aged 18 months to
<13 years-United States, 2008. MMWR Recomm Rep. 57:1–12.
2008.PubMed/NCBI
|
|
4
|
Pakkala S and Ramalingam SS: Lung cancer
in HIV-positive patients. J Thorac Oncol. 5:1864–1871. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Engels EA, Pfeiffer RM, Goedert JJ, Virgo
P, McNeel TS, Scoppa SM and Biggar RJ: HIV/AIDS Cancer Match Study:
Trends in cancer risk among people with AIDS in the United States
1980–2002. AIDS. 20:1645–1654. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Robbins HA, Pfeiffer RM, Shiels MS, Li J,
Hall HI and Engels EA: Excess cancers among HIV-infected people in
the United States. J Natl Cancer Inst. 107:dju5032015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rengan R, Mitra N, Liao K, Armstrong K and
Vachani A: Effect of HIV on survival in patients with
non-small-cell lung cancer in the era of highly active
antiretroviral therapy: A population-based study. Lancet Oncol.
13:1203–1209. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Engsig FN, Kronborg G, Larsen CS, Pedersen
G, Pedersen C, Gerstoft J and Obel N: Lung cancer in HIV patients
and their parents: A Danish cohort study. BMC Cancer. 11:2722011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Clifford GM, Lise M, Franceschi S, Egger
M, Bouchardy C, Korol D, Levi F, Ess S, Jundt G, Wandeler G, et al:
Lung cancer in the Swiss HIV cohort study: Role of smoking,
immunodeficiency and pulmonary infection. Br J Cancer. 106:447–452.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lanoy E, Spano JP, Bonnet F, Guiguet M,
Boué F, Cadranel J, Carcelain G, Couderc LJ, Frange P, Girard PM,
et al: The spectrum of malignancies in HIV-infected patients in
2006 in France: The ONCOVIH study. Int J Cancer. 129:467–475. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dal Maso L, Polesel J, Serraino D, Lise M,
Piselli P, Falcini F, Russo A, Intrieri T, Vercelli M, Zambon P, et
al: Pattern of cancer risk in persons with AIDS in Italy in the
HAART era. Br J Cancer. 100:840–847. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Petoumenos K, Hui E, Kumarasamy N, Kerr
SJ, Choi JY, Chen YM, Merati T, Zhang F, Lim PL, Sungkanuparph S,
et al: Cancers in the TREAT Asia HIV observational database
(TAHOD): A retrospective analysis of risk factors. J Int AIDS Soc.
13:512010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okuma Y, Tanuma J, Kamiryo H, Kojima Y,
Yotsumoto M, Ajisawa A, Uehira T, Nagai H, Takeda Y, Setoguchi Y
and Okada S: A multi-institutional study of clinicopathological
features and molecular epidemiology of epidermal growth factor
receptor mutations in lung cancer patients living with human
immunodeficiency virus infection. J Cancer Res Clin Oncol.
141:1669–1678. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ciuleanu T, Brodowicz T, Zielinski C, Kim
JH, Krzakowski M, Laack E, Wu YL, Bover I, Begbie S, Tzekova V, et
al: Maintenance pemetrexed plus best supportive care versus placebo
plus best supportive care for non-small-cell lung cancer: A
randomised, double-blind, phase 3 study. Lancet. 374:1432–1440.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sandler A, Gray R, Perry MC, Brahmer J,
Schiller JH, Dowlati A, Lilenbaum R and Johnson DH:
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell
lung cancer. N Engl J Med. 355:2542–2550. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
HIV Classification: CDC and WHO Staging
Systems. https://www.aidsetc.org/guide/hiv-classification-cdc-and-who-staging-systemsAccessed.
November 23–2016.
|
|
17
|
The Japan lung cancer society: guideline
for diagnosis and treatment of lung cancer 2015. https://www.haigan.gr.jp/modules/guideline/index.php?content_id=3Accessed.
November 23–2016.
|
|
18
|
Okuma Y, Yanagisawa N, Hosomi Y, Imamura
A, Okamura T, Kato K and Negishi K: Concomitant chemoradiotherapy
and antiretroviral therapy for HIV-infected patients with
locoregionally advanced non-small cell lung cancer: Benefit and
tolerability of treatment in 2 cases. Onkologie. 36:586–590. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Irwin LE, Begandy MK and Moore TM:
Adenosquamous carcinoma of the lung and the acquired
immunodeficiency syndrome. Ann Intern Med. 100:1581984. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wistuba II, Behrens C, Milchgrub S,
Virmani AK, Jagirdar J, Thomas B, Ioachim HL, Litzky LA, Brambilla
EM, Minna JD and Gazdar AF: Comparison of molecular changes in lung
cancers in HIV-positive and HIV-indeterminate subjects. JAMA.
279:1554–1559. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lavolé A, Chouaïd C, Baudrin L, Wislez M,
Raguin G, Pialoux G, Girard PM, Milleron B and Cadranel J: Effect
of highly active antiretroviral therapy on survival of HIV infected
patients with non-small-cell lung cancer. Lung Cancer. 65:345–350.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
White CS, Haramati LB, Elder KH, Karp J
and Belani CP: Carcinoma of the lung in HIV-positive patients:
Findings on chest radiographs and CT scans. AJR Am J Roentgenol.
164:593–597. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Grubb JR, Moorman AC, Baker RK and Masur
H: The changing spectrum of pulmonary disease in patients with HIV
infection on antiretroviral therapy. AIDS. 20:1095–1107. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rudek MA, Moore PC, Mitsuyasu RT, Dezube
BJ, Aboulafia D, Gerecitano J, Sullivan R, Cianfrocca ME, Henry DH,
Ratner L, et al: A phase 1/pharmacokinetic study of sunitinib in
combination with highly active antiretroviral therapy in human
immunodeficiency virus-positive patients with cancer: AIDS
Malignancy Consortium trial AMC 061. Cancer. 120:1194–1202. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Inoue A, Sugawara S, Yamazaki K, Maemondo
M, Suzuki T, Gomi K, Takanashi S, Inoue C, Inage M, Yokouchi H, et
al: Randomized phase II trial comparing amrubicin with topotecan in
patients with previously treated small-cell lung cancer: North
Japan lung cancer study group trial 0402. J Clin Oncol.
26:5401–5406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mitsudomi T, Morita S, Yatabe Y, Negoro S,
Okamoto I, Tsurutani J, Seto T, Satouchi M, Tada H, Hirashima T, et
al: Gefitinib versus cisplatin plus docetaxel in patients with
non-small-cell lung cancer harbouring mutations of the epidermal
growth factor receptor (WJTOG3405): An open label, randomised phase
3 trial. Lancet Oncol. 11:121–128. 2010. View Article : Google Scholar : PubMed/NCBI
|
